Antiblastic chemotherapy in the presence of abdominal aorta aneurysm (AAA)

Guidelines

Salvatore Lauro, Gaetano Lanzetta, Emilio Bria, Luciana Trasatti, Alain Gelibter, Aldo Vecchione

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Concominant neoplasm and abdominal aortic aneurysm (AAA) is not a rare clinical association and can pose problems if antiblastic treatment is required. The literature shows lack of consensus owing to the fact that AAA can modify the liquid load and the hemodynamic setting so that chemotherapy toxicily profile becomes important and hydralion overload increases the AAA-breakage risk. We have analyzed the possibility of treatment with a non-critical water load related chemotherapy in these patients, and if it can offer benefit it terms of overall survival (OS) and quality of life (QL). We concluded thatin chemotherapy the presence of AAA does not have to be excluded first, if such critical parameters such as response to chemotherapy AAA-breakage risk vascular and extravascular toxicity do not compromise the OS and QL of the patients.

Original languageEnglish
Pages (from-to)1439-1444
Number of pages6
JournalAnticancer Research
Volume19
Issue number2 B
Publication statusPublished - 1999

Fingerprint

Abdominal Aorta
Aneurysm
Guidelines
Drug Therapy
Quality of Life
Survival
Abdominal Aortic Aneurysm
Blood Vessels
Hemodynamics
Water
Therapeutics
Neoplasms

Keywords

  • Abdominal aortic aneurysm
  • Chemotherapy
  • Neoplasm

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lauro, S., Lanzetta, G., Bria, E., Trasatti, L., Gelibter, A., & Vecchione, A. (1999). Antiblastic chemotherapy in the presence of abdominal aorta aneurysm (AAA): Guidelines. Anticancer Research, 19(2 B), 1439-1444.

Antiblastic chemotherapy in the presence of abdominal aorta aneurysm (AAA) : Guidelines. / Lauro, Salvatore; Lanzetta, Gaetano; Bria, Emilio; Trasatti, Luciana; Gelibter, Alain; Vecchione, Aldo.

In: Anticancer Research, Vol. 19, No. 2 B, 1999, p. 1439-1444.

Research output: Contribution to journalArticle

Lauro, S, Lanzetta, G, Bria, E, Trasatti, L, Gelibter, A & Vecchione, A 1999, 'Antiblastic chemotherapy in the presence of abdominal aorta aneurysm (AAA): Guidelines', Anticancer Research, vol. 19, no. 2 B, pp. 1439-1444.
Lauro S, Lanzetta G, Bria E, Trasatti L, Gelibter A, Vecchione A. Antiblastic chemotherapy in the presence of abdominal aorta aneurysm (AAA): Guidelines. Anticancer Research. 1999;19(2 B):1439-1444.
Lauro, Salvatore ; Lanzetta, Gaetano ; Bria, Emilio ; Trasatti, Luciana ; Gelibter, Alain ; Vecchione, Aldo. / Antiblastic chemotherapy in the presence of abdominal aorta aneurysm (AAA) : Guidelines. In: Anticancer Research. 1999 ; Vol. 19, No. 2 B. pp. 1439-1444.
@article{deab9b7fbdc349cf8687391730e7a234,
title = "Antiblastic chemotherapy in the presence of abdominal aorta aneurysm (AAA): Guidelines",
abstract = "Concominant neoplasm and abdominal aortic aneurysm (AAA) is not a rare clinical association and can pose problems if antiblastic treatment is required. The literature shows lack of consensus owing to the fact that AAA can modify the liquid load and the hemodynamic setting so that chemotherapy toxicily profile becomes important and hydralion overload increases the AAA-breakage risk. We have analyzed the possibility of treatment with a non-critical water load related chemotherapy in these patients, and if it can offer benefit it terms of overall survival (OS) and quality of life (QL). We concluded thatin chemotherapy the presence of AAA does not have to be excluded first, if such critical parameters such as response to chemotherapy AAA-breakage risk vascular and extravascular toxicity do not compromise the OS and QL of the patients.",
keywords = "Abdominal aortic aneurysm, Chemotherapy, Neoplasm",
author = "Salvatore Lauro and Gaetano Lanzetta and Emilio Bria and Luciana Trasatti and Alain Gelibter and Aldo Vecchione",
year = "1999",
language = "English",
volume = "19",
pages = "1439--1444",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2 B",

}

TY - JOUR

T1 - Antiblastic chemotherapy in the presence of abdominal aorta aneurysm (AAA)

T2 - Guidelines

AU - Lauro, Salvatore

AU - Lanzetta, Gaetano

AU - Bria, Emilio

AU - Trasatti, Luciana

AU - Gelibter, Alain

AU - Vecchione, Aldo

PY - 1999

Y1 - 1999

N2 - Concominant neoplasm and abdominal aortic aneurysm (AAA) is not a rare clinical association and can pose problems if antiblastic treatment is required. The literature shows lack of consensus owing to the fact that AAA can modify the liquid load and the hemodynamic setting so that chemotherapy toxicily profile becomes important and hydralion overload increases the AAA-breakage risk. We have analyzed the possibility of treatment with a non-critical water load related chemotherapy in these patients, and if it can offer benefit it terms of overall survival (OS) and quality of life (QL). We concluded thatin chemotherapy the presence of AAA does not have to be excluded first, if such critical parameters such as response to chemotherapy AAA-breakage risk vascular and extravascular toxicity do not compromise the OS and QL of the patients.

AB - Concominant neoplasm and abdominal aortic aneurysm (AAA) is not a rare clinical association and can pose problems if antiblastic treatment is required. The literature shows lack of consensus owing to the fact that AAA can modify the liquid load and the hemodynamic setting so that chemotherapy toxicily profile becomes important and hydralion overload increases the AAA-breakage risk. We have analyzed the possibility of treatment with a non-critical water load related chemotherapy in these patients, and if it can offer benefit it terms of overall survival (OS) and quality of life (QL). We concluded thatin chemotherapy the presence of AAA does not have to be excluded first, if such critical parameters such as response to chemotherapy AAA-breakage risk vascular and extravascular toxicity do not compromise the OS and QL of the patients.

KW - Abdominal aortic aneurysm

KW - Chemotherapy

KW - Neoplasm

UR - http://www.scopus.com/inward/record.url?scp=0032995494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032995494&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 1439

EP - 1444

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2 B

ER -